Diarrhea in Palliative Care Patients

REFERENCES

• Driscoll C E. Symptom control in terminal illness. Primary Care. 1987; 14: 353–63
   PubMed Web of Science ®Google Scholar
• Levy M H, Catalano R B. Control of common physical symptoms other than pain in patients with terminal disease. Seminars in Oncology. 1985; 12: 411–30
   Google Scholar
• Rousseau P. Nonpain symptom management in terminal care. Clin Geriatr Med. 1996; 12: 313–27
   PubMedGoogle Scholar
• Sykes N P. Constipation and diarrhoea. Oxford Textbook of Palliative Medicine, D Doyle, G WC Hanks, N MacDonald. Oxford University Press;, New York, NY 1993; 299–310
   Google Scholar
• Connolly G, Shanson D, Hawkins D, Harcourt-Webster J, Gazzard B. Noncryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. Gut. 1989; 30: 195–200
   Google Scholar
• Holmes S. Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud. 1989; 26: 69–79
   PubMed Web of Science ®Google Scholar
• Anderson D M. Dorland's Illustrated Medical Dictionary, 28th ed. W.B. Saunders Company, Philadelphia, PA 1994
   Google Scholar
• McGowan I, Allason-Jones E. Symptomatic management of HIV associated gastrointestinal disease. Cancer Surv. 1994; 21: 157–77
   Google Scholar
• Threlkeld D, Hageman R, Brantley A, et al. Drug Facts and Comparisons. Facts and Comparisons;, St. Louis 1997
   Google Scholar
• Fine K. Pathophysiology/Diagnosis/Management. Sleisenger and Fordtran's Gastrointestinal and Liver Disease, M Feldman, M Sleisenger, B Scharschmidt. W. B. Saunders Company;, Philadelphia, PA 1998
   Google Scholar
• Condon J, Wolverson R, South M, Brinkley D. Radiation diarrhoea and cholestyramine. Postgrad Med J. 1978; 54: 838–9
   Google Scholar
• Mennie A, Dalley V, Dinneen L, Collier H. Treatment of radiation-induced gastrointestinal distress with acetylsalicylate. Lancet 1975. 1975; 2: 942–3
   Google Scholar
• Geelhoed G, Bass B, Mertz S, Becker K. Somatostatin analog: effects on hypergastrinemia and hypercalcitoninemia. Surgery. 1986; 100: 962–70
   Google Scholar
• Brabant G, Muller M, Rotsch M, Havemann K, Schmidt F, Hesch R. Treatment of carcinoid syndrome and VIPoma with a long-acting somatorstatin analogue (SMS 201–995). Scand J Gastroenterol. 1986; 21: 177–80
   Web of Science ®Google Scholar
• Vinik A, Tsai S, Moattari A, Cheung P, Eckhauser F, Cho K. Somatostatin analogue (SMS 201–995) in the management of gastroenteropancreatic tumors and diarrhea syndromes. Am J Med. 1986; 81: 23–40
   PubMed Web of Science ®Google Scholar
• Kim-Sing A, Yoshida E, Whittaker J. Palliative high-dose octreotide in a case of severe AIDS-related diarrhea. Ann Pharmacother. 1994; 28: 806–7
   Google Scholar
• Fanning M, Monte M, Sutherland L, Broadhead M, Murphy G, Harris A. Pilot study of Sandostatin (octreotide) therapy of refractory HIV-associated diarrhea. Dig Dis Sci. 1991; 36: 476–80
   PubMedGoogle Scholar
• Cello J, Grendell J, Basuk P. Effect of octreotide on refractory AIDS-associated diarrhea. A prospective, multicenter clinical trial. Ann Int Med. 1991; 115: 705–10
   PubMed Web of Science ®Google Scholar
• Robinson E, Fogel R. SMS 201–995, a somatostatin analogue, and diarrhoea in the acquired immunodeficiency syndrome. Ann Intern Med. 1988; 109: 680–1
   Google Scholar
• Romeu J, Miro J, Cirera G. Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS. 1991; 5: 1495–9
   PubMedGoogle Scholar
• Rene E, Regnier B, Laine M, Bonfils S. Somatostatin and cryptosporidial diarrhoea during AIDS. Can J Physiol Pharmacol. 1986; 64(suppl)70
   Google Scholar
• Kreinik G, Burstein O, Landor M, Bernstein L, Weiss L, Wittner M. Successful management of intractable cryptosporidial diarrhoea with intravenous octreotide, a somatostatin analogue. AIDS. 1991; 5: 765–7
   PubMedGoogle Scholar
• Katz M, Erstad B, Rose C. Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS. Drug Intell Clin Pharm. 1988; 22: 134–6
   Google Scholar
• Cook D, Kelton J, Stanisz A, Collins S. Somatostatin treatment for cryptosporidial diarrhoea in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988; 108: 708–9
   PubMed Web of Science ®Google Scholar
• Clotet B, Cofan F, Materola J, Foz M. Efficacy of the somatostatin analogue (SMS-201–995), Sandostatin, for cryptosporidial diarrhoea in patients with AIDS. AIDS. 1989; 3: 857–8
   Google Scholar
• Brunton L. Agents affecting gastrointestinal water flux and motility; emesis an antiemetics; bile acids and pancreatic enzymes. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th edition, J Hardman, L Limbird, P Molinoff, R Ruddon, A Gilman. McGraw-Hill, New York 1996; 901–36
   Google Scholar
• Mercadante S. The role of octreotide in palliative care. J Pain Symptom Manage. 1994; 9: 406–11
   PubMedGoogle Scholar